Chemical Business Newsbase articles from April 2006, page 4

Chemical Business Newsbase archives from April 2006

Isotis made a loss in 1Q 2006.
April 29, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss biotechnology company Isotis SA in Lausanne (with the operative headquarters in Irvine, CA in the US) achieved a rise in turnover to $9.81 M in 1Q 2006 ($7.81 M in 1Q 2005)...

Surge in turnover for Quadrant in 1Q 2006.
April 29, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss speciality plastics manufacturer Quadrant achieved a 75% rise in net turnover to SFR 213.6 M in 1Q 2006. The rise has been primarily attributed to the acquisition of US...

Sika with excellent start to 2006.
April 29, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss Sika Group, which specialises in speciality chemicals for the construction and automotive segments, achieved a net turnover of SFR 829 M in 1Q 2006 (+38.6%). Numerous...

Syngenta and DuPont exchange technology in Crop Protection.
April 29, 2006... (From Chemical Business NewsBase - Terra e Vita) Syngenta and DuPont have agreed to widen the range of products offered for plant protection by both companies. Syngenta will acquire an exclusive world licence for development of the new...

Medical marijuana: reefer madness.
April 29, 2006... (From Chemical Business NewsBase - Economist) The potential medical uses of cannabis are discussed in the light of the statement issued by the Food and Drug Administration on 20 Apr 2006 that smoking marijuana has no accepted medical uses...

HLL 4Q 2005-2006 net profit rises 76.9%: Rup 2.02 bn from 'Nihar' brand sale.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Hindustan Lever Ltd (HLL) has posted a 76.9% increase in net profit (inclusive of exceptional item of Rup 1488.8 M) of Rup 4428.6 M on net sales of Rup 27.9805 bn for 4Q ended Mar 2006...

Hindustan Zinc 4Q 2005-2006 net profit, sales zoom.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Hindustan Zinc Ltd has recorded a net profit of Rup 8.02 bn on net sales of Rup 17.74 bn for 4Q ended Mar 2006 (net profit of Rup 2.2 bn on net sales of Rup 7.33 bn in 4Q ended Mar 2005)....

GAIL net profit dips 22% in 4Q 2005-2006: Decline mainly due to increase in subsidy burden.
April 29, 2006... (From Chemical Business NewsBase - Business Line) GAIL (India) Ltd (GAIL) has reported a 22% decline in profit-after-tax (PAT) at Rup 4.09 bn on a turnover of Rup 36.6 bn for 4Q 2005-2006 (PAT of Rup 5.24 bn on a turnover of Rup 32.85 bn...

Glenmark net profit down 14% for 2005-2006.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Glenmark Pharmaceuticals Ltd (Glenmark) has posted a 14% decline in consolidated net profit at Rup 907.4 M on 23% higher consolidated revenues at Rup 7557.9 M for the year ended Mar 2006....

Orchid Chemicals 4Q 2005-2006 net profit up, to pay 30% dividend.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Orchid Chemicals and Pharmaceuticals Ltd has registered a net profit of Rup 193 M on a turnover of Rup 2398.4 M for 4Q ended Mar 2006 (net profit of Rup 166 M on a turnover of Rup 1781 M...

P&G 3Q ended Mar 2006 net profit up 81%.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Procter & Gamble Hygiene and Healthcare Ltd (P&G) has recorded an 81% increase in net profit at Rup 265.4 M on total income of Rup 1241 M for 3Q ended Mar 2006 (net profit of Rup 146.6 M...

Alembic sales, profit higher for 2005-2006.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Alembic Ltd has posted a 51% higher net profit at Rup 785.2 M on 16% increase in sales at Rup 6659.2 M for the year ended Mar 2006. The company reported 25% higher sales of formulations in...

Ajanta Pharma 4Q 2005-2006 net profit up 36%.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Ajanta Pharma has reported a 36% increase in net profit at Rup 54.6 M on net sales of Rup 749.1 M for 4Q ended Mar 2006 (net profit of Rup 40.2 M on net sales of Rup 694.2 M in 4Q ended...

JK Ind 2Q 2005-2006 net profit at Rup 45 M.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Tyre manufacturer JK Industries Ltd has recorded a net profit of Rup 45 M on net sales of Rup 6250.4 M for 2Q ended Mar 2006 (net loss of Rup 19.9 M on net sales of Rup 4903 M in 2Q ended...

Grasim to spend Rup 45 bn on capex.
April 29, 2006... (From Chemical Business NewsBase - Business Line) Grasim Industries (Grasim) plans to invest about Rup 45 bn as capital expenditure (capex) to increase its cement production capacity by 8 M tonnes and its viscose staple yarn capacity by...

Finolex: Results for 4Q and 2005-2006. [2 tables in original article].
April 29, 2006... (From Chemical Business NewsBase - Business Line) Finolex Industries Ltd (Finolex) has registered a net profit of Rup 153.67 M on net sales/income from operations of Rup 2474.756 M for 4Q ended Mar 2006 (net profit of Rup 276.532 M on net...

GSK Pharma sells animal health biz to Virbac.
April 29, 2006... (From Chemical Business NewsBase - Business Line) GlaxoSmithKline Pharmaceuticals Ltd (GSK) plans to divest its stand alone animal health business in India Agrivet Farm Care to Virbac Animal Health India Ltd (Virbac) for Rup 2.071 bn by...

GSK Pharma 1Q 2006 net profit up 115.79%.
April 29, 2006... (From Chemical Business NewsBase - Business Line) GlaxoSmithKline Pharmaceuticals (GSK Pharma) has posted a 115.79% higher net profit at Rup 1012.3 M on total income (net of excise) of Rup 4483.9 M for 1Q ended Mar 2006 (net profit of Rup...

Dalmia Cement: Results for 2005-2006. [2 tables in original article].
April 29, 2006... (From Chemical Business NewsBase - Business Line) Dalmia Cement (Bharat) Ltd (Dalmia Cement) has recorded a net profit of Rup 535.3 M on net sales (including excise duty) of Rup 1834.7 M for 4Q ended Mar 2006 (net profit of Rup 121.1 M on...

Cadila: Results for 4Q 2005-2006. [2 tables in original article].
April 29, 2006... (From Chemical Business NewsBase - Business Line) Pharma firm Cadila Healthcare Ltd (Cadila) has recorded a net profit of Rup 223 M on net sales of Rup 2.768 bn for 4Q ended Mar 2006 (net profit of Rup 159 M on net sales of Rup 1.933 bn...

Call for biowar on drugs in US.
April 29, 2006... (From Chemical Business NewsBase - New Scientist UK Edition) Mark Souder, a Republican Congressman from Indiana, has introduced a provision into a US bill that would allow the use of the fungus Fusarium oxysporin as a biological control...

Technip awarded contract for a new biodiesel unit in France.
April 29, 2006... (From Chemical Business NewsBase - Press Release) Technip has been awarded by Diester Industrie a turnkey contract for a new biodiesel unit, based on the Axens process, to be built in Montoir-de-Bretagne, near Saint Nazaire, France. The...

Coley Pharmaceutical Group presents data from clinical study of Actilon for hepatitis C at the European Association for the study of the liver meeting.
April 29, 2006... (From Chemical Business NewsBase - Press Release) Coley Pharmaceutical Group Inc (Coley) announced positive four-and twelve-week treatment data from company's five-arm Phase Ib clinical study of Actilon (CPG 10101) alone and in...

Researchers report initial results for 14-day Phase Ib study of VX-950, and pegylated interferon, showing anti-HCV activity in combination in hepatitis C patients.
April 29, 2006... (From Chemical Business NewsBase - Press Release) Data presented at the 41st Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna show that when VX-950, an investigational oral hepatitis C virus (HCV)...

Favourable antiviral activity and improved tolerability demonstrated by valopicitabine 200 mg/day in combination with pegylated interferon in an ongoing Phase IIb trial in treatment-naive genotype 1 patients.
April 29, 2006... (From Chemical Business NewsBase - Press Release) Idenix Pharmaceuticals Inc announced that the 200 mg/day dose level of the investigational agent, valopicitabine (NM283), combined with pegylated interferon demonstrated comparable...

New oral polymerase inhibitor shows promising results in chronic hepatitis C patients.
April 29, 2006... (From Chemical Business NewsBase - Press Release) A new class of hepatitis C therapies called polymerase inhibitors, demonstrates an antiviral effect by achieving clinically significant viral load reductions in chronic hepatitis C...

Pegasys accelerate trial shows six months of treatment is optimal for achieving success in category of hepatitis C patients.
April 29, 2006... (From Chemical Business NewsBase - Press Release) Roche announced that results from a new trial have shown that 24 weeks of therapy with Pegasys (peginterferon alfa-2a) combined with ribavirin is more effective than 16 weeks for patients...

EU production capacity for biodiesel rises 44%.
April 28, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Biodiesel capacity in the 25 EU countries will rise 44% in 2006 to 6.07 M tonnes. Production was 3.2 M tonnes in 2005, a rise of 65% on 2004. Germany, France and Italy were...

The week ahead in the European Parliament 2-5 May 2006: paediatric medicines.
April 28, 2006... (From Chemical Business NewsBase - EP News - European Parliament) On 4 May 2006, the environment and public health committee of the European Parliament is due to adopt, at the second reading stage, a draft recommendation on the use of...

Siemens acquires immunodiagnostics company.
April 28, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Siemens subsidiary Medical Solutions is to acquire US company Diagnostic Products Corp (DPC) for $1.86 bn. The deal is to be completed in summer 2006. DPC is a leading...

France: 2006 will be a good year for the chemical industry.
April 28, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) France's chemical industry posted a 3% rise in domestic output in 2005. Imports rose almost 8% and investment was up almost 9% to EUR 3.2 bn. Production, imports and...

Nexavar receives positive opinion from European Committee for Medicinal Products for Human Use.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Bayer Pharmaceuticals Corp (Bayer) and Onyx Pharmaceuticals Inc have received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) for Nexavar...

Phosphagenics and Nestle Nutrition sign agreement for development of Phospha E for foods and beverages.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Phosphagenics Ltd and Nestle Nutrition have entered into a research agreement to develop Phosphagenics' Phospha E for use in Nestle Nutrition's products. Products containing this superior...

Adventrx announces closing of merger with SD Pharmaceuticals.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Adventrx Pharmaceuticals Inc announced the closing of the merger between the company and privately-held SD Pharmaceuticals Inc (SD Pharma). Adventrx acquired all outstanding shares of SD...

SkyePharma announces first European approval of DepoDur.
April 28, 2006... (From Chemical Business NewsBase - Press Release) SkyePharma PLC announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery....

Pharmacokinetic data for Nastech's intranasal parathyroid hormone (PTH1-34) demonstrated similar profile to approved injectable product.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Nastech Pharmaceutical Co Inc (Nastech) presented data from a Phase I pharmacokinetic study of Parathyroid Hormone (PTH1-34) nasal spray demonstrating a similar pharmacokinetic profile to...

Acuity Pharmaceuticals enters agreement to develop anti-inflammatory siRNA for ophthalmic uses.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Acuity Pharmaceuticals (Acuity) has entered into a licence option agreement with ZaBeCor Pharmaceutical Co (ZaBeCor) for exclusive development and commercialization rights to ophthalmic...

Corgentech announces presentation of 3268 Phase III data at 2006 Pediatric Academic Societies' annual meeting.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Corgentech Inc announced that data from a Phase III trial of 3268, a fast-acting local anaesthetic aimed at reducing pain associated with venipunctures and intravenous line placements...

Biomira announces final Phase IIb survival results of Stimuvax (formerly known as BLP25 Liposome Vaccine) trial in patients with non-small cell lung cancer.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Biomira Inc announced final survival results from an exploratory analysis of the Phase IIb clinical trial data. The randomized, open-label trial tested the clinical potential of Stimuvax...

Abbott's Humira receives positive opinion from European Medicines Agency for the treatment of ankylosing spondylitis.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Abbott announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, granted a positive opinion recommending approval of...

ZaBeCor Pharmaceutical Co licenses its anti-inflammatory siRNA technology to Acuity Pharmaceuticals for ophthalmic uses.
April 28, 2006... (From Chemical Business NewsBase - Press Release) ZaBeCor Pharmaceutical Co (ZaBeCor) has entered into a licence option agreement with Acuity Pharmaceuticals (Acuity), with Acuity to receive exclusivity for ophthalmologic uses of...

Biosyntrx's dry eye formulation awarded US patent.
April 28, 2006... (From Chemical Business NewsBase - Press Release) The US Patent and Trademark Office has awarded patent No 7,029,712 to Biosyntrx's BioTears Oral GelCaps, a dry eye, tear film integrity formulation. Nutrients included in the BioTears oral...

Labopharm announces pricing of public offering.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Labopharm Inc announced the public offering of 11 M of its common shares at a price of $8.00, representing an increase of 1 M shares from the 10 M shares originally proposed to be offered....

Staar Surgical submits application to FDA for the Visian Toric ICL (Visian TICL).
April 28, 2006... (From Chemical Business NewsBase - Press Release) Staar Surgical Co (Staar) has submitted a Pre-Market Approval (PMA) supplement to the US Food and Drug Administration (FDA) for its Visian TICL, a toric implantable Collamer lens designed...

Genencor to provide i-mune assay evaluation services to BioMarin Pharmaceutical Inc.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Genencor International Inc (Genencor) announced it has signed a contract research agreement with BioMarin Pharmaceutical Inc for the use of Genencor's proprietary i-mune assay platform to...

FDA approves Genzyme's Myozyme for all patients with pompe disease.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Genzyme Corp announced that the Food and Drug Administration has granted marketing approval for Myozyme (alglucosidase alfa) in the US. Myozyme has been approved for the treatment of...

Johnson & Johnson Pharmaceutical Research & Development & Grunenthal GmbH to initiate Phase III trials of novel analgesic for moderate to severe acute pain.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Johnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD), together with Ortho-McNeil Pharmaceutical Inc, announced that it will initiate Phase III studies of tapentadol...

Royal Dutch Shell plc: Buyback of own shares.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Royal Dutch Shell plc announces that on 28 Apr 2006 it purchased for cancellation 600,000 "A" Shares at a price of EUR 27.23/share. It further announces that on the same date it purchased...

Pfizer's Sutent receives positive opinion in the European Union for two difficult-to-treat advanced cancers.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Pfizer Inc said that the Committee for Human Medicinal Products (CHMP) issued a positive opinion recommending conditional marketing authorization for Pfizer's new cancer medicine Sutent...

Motiva announces progress on refinery expansion project.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Royal Dutch Shell plc welcomed the announcement by Motiva Enterprises LLC (Motiva) that it has made significant progress toward expanding refining capacity in the US. Motiva has completed...

Abbott's new tablet formulation of Kaletra (lopinavir/ritonavir) receives positive opinion from the European Medicines Agency.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Abbott announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued a positive opinion...

Ciba's profitability decreased further in 1Q 2006. Launch of a new programme to improve efficiency. [1 table in original article].
April 28, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss Ciba Group achieves a 11% rise in turnover to SFR 1645 M in 1Q 2006. Profits (excluding the sold textile business) would have increased by 5% if negative currency exchange...

Bayer's pharmaceuticals segment gains in strength.
April 28, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) German pharmaceuticals and chemicals group Bayer, which will shortly acquire Schering, achieved a 12% rise in group turnover to EUR 7.5 M in 1Q 2006. The operating result...

Merck increases targets for 2006.
April 28, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) German pharmaceuticals and chemicals group Merck in Darmstadt targets a turnover increase of between 5-10% in 2006. In 1Q 2006 turnover increased by 16% to EUR 1.58 bn fuelled by...

Favourable results for Straumann in 1Q 2006.
April 28, 2006... (From Chemical Business NewsBase - Neue Zuercher Zeitung) Swiss dental implants manufacturer Straumann achieved a 26.5% rise in turnover to SFR 158.9 M in 1Q 2006. Favourable currency exchange rates contributed 4% to the turnover...

Lundbeck applies for European approval of Cipralex to treat obsessive compulsive disorder.
April 28, 2006... (From Chemical Business NewsBase - Net Posten) H Lundbeck has submitted to the Swedish authorities an application for approval of Cipralex for the treatment of obsessive compulsive disorder (OCD) in the EU. Sweden serves as a reference...

Novo Nordisk hitch with FDA approval of insulin analogues.
April 28, 2006... (From Chemical Business NewsBase - Net Posten) Novo Nordisk has received a 'Not Approvable Letter' from the FDA concerning the company's application for approval of its insulin analogues NovoLog Mix 30/70 and NovoLog Mix 50/50 which was...

USA obesity could ensure solid growth for Novo Nordisk.
April 28, 2006... (From Chemical Business NewsBase - Net Posten) New research at Harvard University suggests that there are far more cases of obesity in the US population than had been previously thought. Obesity is linked with a sharply increased risk of...

Novo Nordisk sales up 23% in 1Q 2006.
April 28, 2006... (From Chemical Business NewsBase - Net Posten) In 1Q 2006 Novo Nordisk achieved an overall sales growth of 23%, with sales of insulin analogues rising by 60% and sales of NovoSeven by 16%. Sales in N America grew by 32%. Results from...

Herceptin gets European approval in record time.
April 28, 2006... (From Chemical Business NewsBase - The Independent) The breast cancer drug Herceptin has been approved in record time on the way to gaining a licence for use in early cases of the disease. The revolutionary drug was given the green light...

Profits surge gives injection to GSK and AstraZeneca shares.
April 28, 2006... (From Chemical Business NewsBase - The Independent) The drug giants GlaxoSmithKline and AstraZeneca saw profits soar during the first three months of 2006. GSK, Europe's biggest drug maker, was bullish on 27 Apr 2006 on the outlook for...

Smith & Nephew becomes casualty of NHS spending cuts.
April 28, 2006... (From Chemical Business NewsBase - The Independent) The hips-to-knees maker Smith & Nephew slashed its annual growth forecast on 27 Apr 2006 after 1Q 2006 earnings were hit by a restructuring of the business and cutbacks in government...

Refining margins lift Reliance: 4Q 2005-2006 net profit up at Rup 25.02 bn, board declares 100% dividend. [1 table in original article].
April 28, 2006... (From Chemical Business NewsBase - Business Line) Reliance Industries Ltd (Reliance) has reported a net profit of Rup 25.02 bn on a net turnover of Rup 245.420 bn for 4Q ended Mar 2006 (net profit of Rup 22.92 bn on a net turnover of Rup...

IOC nets Rup 32.25 bn by diluting stake in ONGC.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Major oil refiner Indian Oil Corp (IOC) has divested 20% of its 9.6% stake in ONGC and realised a profit of over Rup 32.25 bn. IOC plans to utilise the realisations to improve its overall...

Colgate Palmolive 4Q 2005-2006 net profit up 14%.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Colgate Palmolive India Ltd (Colgate Palmolive) has recorded a 14% increase in net profit at Rup 370.1 M on 26% higher net sales at Rup 3.021 bn for 4Q ended Mar 2006 (net profit of Rup...

Glenmark's asthma drug enters Phase II trials.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Glenmark's prospective antiasthmatics drug Oglemilast (GRC 3886) has entered Phase II trials in the US. Forest Laboratories Inc, Glenmark's development partner for North America, is...

Nagarjuna Fert net profit up 126% for 2005-2006.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Nagarjuna Fertilisers and Chemicals Ltd (Nagarjuna Fert) has recorded a 126% increase in net profit at Rup 668.6 M on sales of Rup 14.5295 bn for the year ended Mar 2006 (net profit of Rup...

Supreme Petrochem: Results for 4Q 2005-2006. [1 table in original article].
April 28, 2006... (From Chemical Business NewsBase - Business Line) Polystyrene manufacturer Supreme Petrochem Ltd has reported a net profit of Rup 97.275 M on net sales/income from operations of Rup 4283.810 M for 3Q ended Mar 2006 (net profit of Rup...

Petronet LNG to raise $100 M: The 4Q 2005-2006 net profit jumps.
April 28, 2006... (From Chemical Business NewsBase - Business Line) The board of Petronet LNG has approved the proposal to raise $100 M by issuing foreign currency convertible bonds to part finance its LNG terminal at Kochi. The company reported a net...

BPCL net profit up at Rup 17.883 bn for 4Q 2005-2006.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Bharat Petroleum Corp Ltd (BPCL) has reported a net profit of Rup 17.883 bn on total income of Rup 214.3 bn for 4Q ended Mar 2006 (net profit of Rup 3.514 bn on total income of Rup 161.108...

'New import norms not for non-GM soya oil': Environment Ministry says it is for oil from GM seeds only.
April 28, 2006... (From Chemical Business NewsBase - Business Line) The Ministry of Environment and Forests, Government of India, has stated that the rule making it compulsory for imports of genetically modified (GM) products to carry a declaration from...

Pullangode Rubber: Results for 4Q 2005-2006. [1 table in original article].
April 28, 2006... (From Chemical Business NewsBase - Business Line) The Pullangode Rubber & Produce Co Ltd (Pullangode Rubber) has recorded a profit-after-tax of Rup 2.379 M on net sales/income from operations of Rup 13.63 M for 4Q ended Mar 2006 (loss of...

Grasim 4Q 2005-2006 net profit up 14.5%: Growth led by cement and viscose staple yarn businesses.
April 28, 2006... (From Chemical Business NewsBase - Business Line) Grasim Industries (Grasim) has registered a 14.5% increase in net profit (after extraordinary items) at Rup 2627.4 M on net sales of Rup 18.15 bn for 4Q 2005-2006 (net profit of Rup 2295...

Karur KCP Packkagings: Results for 4Q 2005-2006. [1 table in original article].
April 28, 2006... (From Chemical Business NewsBase - Business Line) Karur KCP Packkagings Ltd has posted a profit-after-tax of Rup 17.005 M on gross sales/income of Rup 795.551 M for 4Q ended Mar 2006 (profit-after-tax of Rup 11.932 M on gross sales/income...

Avanir announces Neurodex Phase III trial results published in Annals of Neurology.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Avanir Pharmaceuticals (Avanir) announced that results of a pivotal Phase III clinical trial evaluating Neurodex for the treatment of patients with involuntary emotional expression...

FibroGen licenses oral HIF-PH inhibitors, including FG-2216 and FG-4592, to Astellas for the treatment of anaemia in Europe and other regions; FibroGen positioned to develop first oral anaemia therapy for North America.
April 28, 2006... (From Chemical Business NewsBase - Press Release) FibroGen Inc has completed an exclusive licensing agreement with Astellas Pharma Inc (Astellas) that provides Astellas rights to certain FibroGen hypoxia-inducible factor (HIF) prolyl...

Sonus Pharmaceuticals to raise $30.6 M in registered direct offering.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Sonus Pharmaceuticals Inc (Sonus) has entered into purchase agreements for the sale of about $30.6 M of its common stock in a registered direct offering. Under the terms of the financing,...

Stem Cell Innovations files patents relating to production of human motor neurons and progenitors; cells may be useful in therapies for ALS, Parkinson's, multiple sclerosis and other neurodegenerative diseases.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Stem Cell Innovations Inc has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells (PCs) into neural progenitor cells and purified...

Xethanol set to expand in New England; company forges NewEnglandXethanol strategic alliance with Global Energy Management.
April 28, 2006... (From Chemical Business NewsBase - Press Release) Xethanol Corp has organized NewEnglandXethanol LLC accelerating its growth plans to roll out ethanol production throughout the East Coast. NewEnglandXethanol will be a strategic alliance...

pSivida quarterly cashflow - Mar 2006 commentary and highlights.
April 28, 2006... (From Chemical Business NewsBase - Press Release) pSivida Ltd released its quarterly cashflow statement for the period ended Mar 2006. Following the acquisition of pSivida Inc (formerly Control Delivery Systems Inc) of 30 Dec 2005, the...

AXM Pharma receives initial proceeds of RMB Yuan 10 M loan from Shenyang Municipal Government.
April 28, 2006... (From Chemical Business NewsBase - Press Release) AXM Pharma Inc, a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, has received the first tranche of a RMB Yuan 10...

Brokerage forecasts Magnesita Q1 2006 earnings of US$8.7 M - Brazil.
April 28, 2006... (From Chemical Business NewsBase - BNAmericas Metals News) Magnesita, the Brazilian magnesite producer, is reported to have made net profits of R$18.2 M in 1Q 2006, somewhat down on the R$30.9 M achieved in 1Q 2005. A slight recovery in...

Petrobras completes Shell downstream purchase - Colombia.
April 28, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Petrobras, the Brazilian federal energy firm, has bought the Colombian fuel distribution and marketing operations of Shell. The deal involves 38 retail filling stations, a...

Pemex starts operations at Lobina oilfield in Gulf of Mexico - Mexico.
April 28, 2006... (From Chemical Business NewsBase - BNAmericas Oil & Gas News) Pemex, the Mexican state oil firm, is now producing 4680 bbl/day of crude oil and 1.57 M cu ft/day of natural gas from its offshore Lobina oilfield in Tamaulipas state, Mexico....